Page last updated: 2024-10-20

pyrazinamide and Vitiligo

pyrazinamide has been researched along with Vitiligo in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raffas, W1
El Amrani, F1
Tbatou, F1
Khalil, F1
Benzekri, A1
Hassam, B1
Benzekri, L1

Other Studies

1 other study available for pyrazinamide and Vitiligo

ArticleYear
[Primary penile tuberculosis].
    Annales de dermatologie et de venereologie, 2013, Volume: 140, Issue:10

    Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Immunocompromised Host; Isonia

2013